PIMCO's Group CIO Dan Ivascyn explains how they avoid overreach in more sensitive areas and focus our income strategy on ...

BioNTech SE is transitioning from a COVID-19 vaccine story to a late-stage oncology platform with a robust $17B cash position. Click to read why BNTX is a Buy.